TAD GLUTATHIONE ITALY 600mg
TAD GLUTATHIONE
MANUFACTURER: Biomedica Foscama, Italy
METHOD OF ADMINISTRATION: via Intravenous route
DOSAGE FOR WHITENING: 2 vials or 1200mg on a 2-3 times per week regimen
PACKAGING: 10 vials of 600mg glutathione powder
MANUFACTURER: Biomedica Foscama, Italy
METHOD OF ADMINISTRATION: via Intravenous route
DOSAGE FOR WHITENING: 2 vials or 1200mg on a 2-3 times per week regimen
PACKAGING: 10 vials of 600mg glutathione powder
ABOUT THE PRODUCT:
AUTHENTICITY: Leaflet ( in English ) and CERTIFICATE OF ANALYSIS as proof of authenticity
DIRECTION: Dissolve 600mg lyophilized powder with 4ml water for injection (reconstituted solution contains 150mg/ml of glutathione)
FACTS AVAILABLE IN THE LEAFLET:
Presentation and Form
IV vial (sterile, white lyophilized powder) 600mg x 10’s
Product Description
Each vial contains glutathione sodium 646mg equivalent to glutathione 600mg
Pharmacodynamic Properties
Glutathione is a physiologic tripeptide – a chain of three amino acids cystein, glycine and glutamic acid: and is irreversibly consume in the detoxification of electrophilic metabolites and xenobiotics. It is very efficient free radical scavenger and protects cell from noxious effect or reactive oxygen compound.
Enhanced oxidative stress has been implicated in the pathogenesis of several disorders; as made evident by the low glutathione levels found in immune compromised individuals , neuro-degenerative diseases such as multiple scelerosis, ALS, Alzheimer's and Parkinson's disease, artherosclerosos, male infertility, pregnancy complications, cataracts, cancer and HIV-infected patients
Published clinical and scientific research has demonstrated the protective effect of glutathione in several pathologic situation which cause cellular damage, as is the case of intoxications from substances such as ethyl alcohol, paracetamol, salicylates, Phenobarbital, tricyclic antidepressants, organophosphorous insecticides, etc.
The mechanism of neurotoxicity induced by chemotherapeutic agents has been proposed to involved the accumulation of platinum within he peripheral nervous system, especially in the dorsal root ganglia. A strategy optimal for reducing the neurotoxicity associated with platinum
AUTHENTICITY: Leaflet ( in English ) and CERTIFICATE OF ANALYSIS as proof of authenticity
DIRECTION: Dissolve 600mg lyophilized powder with 4ml water for injection (reconstituted solution contains 150mg/ml of glutathione)
FACTS AVAILABLE IN THE LEAFLET:
Presentation and Form
IV vial (sterile, white lyophilized powder) 600mg x 10’s
Product Description
Each vial contains glutathione sodium 646mg equivalent to glutathione 600mg
Pharmacodynamic Properties
Glutathione is a physiologic tripeptide – a chain of three amino acids cystein, glycine and glutamic acid: and is irreversibly consume in the detoxification of electrophilic metabolites and xenobiotics. It is very efficient free radical scavenger and protects cell from noxious effect or reactive oxygen compound.
Enhanced oxidative stress has been implicated in the pathogenesis of several disorders; as made evident by the low glutathione levels found in immune compromised individuals , neuro-degenerative diseases such as multiple scelerosis, ALS, Alzheimer's and Parkinson's disease, artherosclerosos, male infertility, pregnancy complications, cataracts, cancer and HIV-infected patients
Published clinical and scientific research has demonstrated the protective effect of glutathione in several pathologic situation which cause cellular damage, as is the case of intoxications from substances such as ethyl alcohol, paracetamol, salicylates, Phenobarbital, tricyclic antidepressants, organophosphorous insecticides, etc.
The mechanism of neurotoxicity induced by chemotherapeutic agents has been proposed to involved the accumulation of platinum within he peripheral nervous system, especially in the dorsal root ganglia. A strategy optimal for reducing the neurotoxicity associated with platinum